Page 12 - Michael Yee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Yee Today - Breaking & Trending Today

Moderna (MRNA) Q4 2023 Earnings Call Transcript

Published: February 22, 2024

MRNA earnings call for the period ending December 31, 2023.

Source: yahoo.com

Related Topics:

United StatesElizabeth Webster Goldman SachsSalveen RichterTerence FlynnJessica Fye JpmorganEllie MerleJessica FyeMichael YeeAmerica Merrill LynchHartaj Singh OppenheimerBoran Wang GuggenheimStephen HogeBevan WangGena WangGena Wang BarclaysLavina TalukdarTerence Flynn Morgan StanleyAlex HammondMike Yee JefferiesHartaj SinghGeoff MeachamCompany AnalystAlex Hammond BankGoldman SachsMorgan Stanley

Moderna reports surprise profit, sets out road map for RSV vaccine

Published: February 22, 2024

Moderna reports surprise profit, sets out road map for RSV vaccine

Source: dunyanews.tv

Related Topics:

United StatesUnited KingdomLee BrownMichael YeeChief Financial Officer James MockThird Bridge

Moderna (MRNA) Q4 2023 Earnings Call Transcript

Published: February 22, 2024

MRNA earnings call for the period ending December 31, 2023.

Source: fool.com

Related Topics:

United StatesElizabeth Webster Goldman SachsJessica FyeMike Yee JefferiesBevan WangJessica Fye JpmorganSalveen RichterGena WangGena Wang BarclaysTerence FlynnAmerica Merrill LynchLavina TalukdarTerence Flynn Morgan StanleyStephen HogeHartaj Singh OppenheimerBoran Wang GuggenheimMichael YeeEllie MerleAlex HammondHartaj SinghGeoff MeachamAlex Hammond BankGoldman SachsMorgan StanleyCompany Analyst

Iovance, with approval of 'TIL' cell therapy, readies for complex launch

Published: February 20, 2024

BioPharma

Source: biopharmadive.com

Related Topics:

Jim ZieglerIovance Biotherapeutic AmtagviBenjamin BurnettFrederick VogtBristol MyersMichael YeePeter MarksGilead SciencesDrug AdministrationNational Institutes Of HealthBristol Myers SquibbDive BriefNational InstitutesBiologics EvaluationGene Therapy

AbbVie's Cerevel deal hits an uncommon roadblock

Published: February 20, 2024

BioPharma

Source: biopharmadive.com

Related Topics:

Lina KhanMichael YeeBristol Myers SquibbDrug AdministrationExchange CommissionCerevel TherapeuticsFederal TradeHart Scott Rodino ActHorizon Therapeutics